Brainomix Company
Brainomix has developed automated medical software for stroke image analysis, and lung diseases such as NSCLC and IPF. Our Radiology AI biomarkers enable precision medicine for better treatment.
Investors
%20.jpg)
Founded Date:
2010-01-01
Funding Status:
Early Stage Venture
Total Funding:
35017490
Employee Number:
9
Headquarters:
Oxford, Oxfordshire, United Kingdom
Last Funding Date:
2021-12-16
Investors Number:
6
Last Funding Type:
Series B
Estimated Revenue:
$33.16M
Number Of Exists:
11-50
Industry:
Aging Biomarkers